SaMD Development Support
We apply the applicable EU and US software-qualification tests to intended use, and we engineer the product as medical device software from the design phase whenever SaMD is a reasonable possibility — so later qualification does not force a rebuild of architecture, logs or documentation.
When this is needed
- Intended use may place software in a medical device / SaMD category
- Engineering and RA need a shared plan before claims harden
- The product should be built to regulated-software expectations even if qualification is not yet filed
- Teams need a clear line between wellness / research tooling and medical device software
- AI-enabled clinical decision support raises both device and AI-governance questions
How we work
- Intended use — claims, users, clinical vs non-clinical language
- Qualification view — apply MDCG / FDA / IMDRF software tests to that intended use and state how likely medical-device / SaMD qualification is
- Design as regulated software — lifecycle, risk, logging and evidence from the start when qualification is a reasonable possibility
- Product and documentation plan — engineering collaboration suited to IEC 62304-oriented work
- Coordination — device readiness and regulatory writing as needed; the client remains manufacturer and filing party
See How we work and Medical software for engineering standards (IEC 62304, ISO 14971, ISO 13485-aligned practices).
Qualification
Whether software is medical device software or SaMD is a test against intended use and published frameworks (IMDRF SaMD, MDCG software guidance in the EU, FDA device-software / SaMD guidance in the US). Those tests usually make the likely qualification clear well before any FDA marketing authorization or notified-body certificate. We apply them to the product and give a reasoned view.
- Medical purpose vs wellness, administrative or research-only language
- Users, clinical context and potential harm if the software fails
- Marketing claims vs what the software actually does
- What remains genuinely open vs what the rules already decide
A qualification view is not an FDA, notified-body or competent-authority decision. The client remains the manufacturer, submission holder and party of record for any filing.
Design-phase discipline
Where there is a reasonable chance the product will be SaMD or medical device software, we design and write it that way from the outset: software safety class, risk controls, change history, logs and documentation that a later technical file or DHF can use. That reduces the cost of redesign, retrospective logging and documentation catch-up if qualification is confirmed.
Lifecycle and documentation themes
- Software development planning, safety classification and requirements suitable for later technical-file / DHF inputs
- Risk management inputs (ISO 14971-oriented) tied to software failure modes
- SOUP / third-party component awareness and change control expectations
- Verification and validation evidence planning appropriate to risk class
- Cybersecurity and data-protection design themes proportional to product risk
In scope
- Reasoned SaMD / medical-device-software qualification against applicable frameworks
- Engineering and documentation from design onward when qualification is a reasonable possibility
- Coordination with regulatory documentation and device readiness workstreams
Example deliverables
- Intended-use and qualification notes with a reasoned SaMD / device-software view
- Planning artefacts for engineering and documentation tracks
- Lifecycle, logging and evidence inputs the client can take into QMS and filings
- Traceability and technical-file inputs when scoped with medical-software engineering
Out of scope
- Granting FDA marketing authorization, CE marking or any certificate
- Acting as a notified body, competent authority or the FDA
FAQ
Will you tell us if our app is SaMD?
Yes. We apply the applicable qualification tests to intended use and give a reasoned view of whether the software is likely medical device / SaMD software.
That view is not a substitute for an FDA, notified-body or competent-authority decision. The client remains the manufacturer and filing party.
Why design as SaMD before a formal filing?
If qualification is a reasonable possibility, building to those lifecycle, log and documentation expectations from the design phase is cheaper than re-engineering after claims harden.
Is this the same as medical software engineering?
Closely related. SaMD support is the qualification view plus design-phase discipline when device rules may apply;
medical software is the broader engineering and documentation depth.
Related
Medical software · Regulatory support · Device readiness · Digital health
For role boundaries (regulator, notified body, certification, outcomes), see Trust.
Ready to discuss a programme?
Tell us about your organisation and the type of support you need.